about
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the ful...
Read More
26.67
0.32
(1.21%)
246.7K
XNAS Volume
XNAS 22 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Septerna Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..